Home LiteratureArticle Details
PMID: 1974733 Published · ppublish English Journal Article

Antiinflammatory effects of various drugs on acetic acid induced colitis in the rat.

Agents and actions ·Vol. 30 ·No. 3-4 ·1990-06-00 ·Pages 393-402

Fitzpatrick LR, Bostwick JS, Renzetti M, Pendleton RG, Decktor DL

Abstract

The efficacy of various drugs used to treat ulcerative colitis, (sulfasalazine, 5-aminosalicylate, hydrocortisone) was investigated in a model of acetic acid-induced colitis in the rat. Subsequently, we tested the ability of antioxidant/5-lipoxygenase inhibitors (gossypol and nordihydroguiaretic acid [NDGA]) and a cyclooxygenase inhibitor (indomethacin) to attenuate the macroscopic colonic damage and/or neutrophil influx (myeloperoxidase activity [MPO]) associated with this model of colitis. Oral pretreatment with either sulfasalazine, gossypol, or NDGA significantly decreased colonic MPO activity induced by acetic acid. Intrarectal administration of such drugs resulted in an even larger reduction of the colonic inflammation, with gossypol being the most potent compound. Oral or intrarectal administration of corticosteroids (dexamethasone, hydrocortisone) also attenuated the parameters of acetic acid induced colitis. In contrast, pretreatment with indomethacin was ineffective, or when administered daily after colitis induction, indomethacin actually increased colonic neutrophil influx significantly. Our data suggest that both the route of drug administration and dosing regimen employed affect the antiinflammatory potency and/or efficacy of compounds on colitis induced by acetic acid in the rat. Drugs which were effective against this colitis may act by scavenging of oxygen derived free radicals.

MeSH Terms
Acetates Acetic Acid Aminosalicylic Acids/therapeutic use Animals Anti-Inflammatory Agents Colitis, Ulcerative/chemically induced,drug therapy Dexamethasone/therapeutic use Disease Models, Animal Gossypol/therapeutic use Hydrocortisone/therapeutic use Indomethacin/therapeutic use Intestinal Mucosa/drug effects,pathology Leukocyte Count Male Masoprocol/therapeutic use Mesalamine Neutrophils/enzymology Peroxidase/metabolism Rats Rats, Inbred Strains Sulfasalazine/therapeutic use
Chemicals
Acetates Aminosalicylic Acids Anti-Inflammatory Agents Sulfasalazine Mesalamine Masoprocol Dexamethasone Peroxidase Gossypol Acetic Acid Hydrocortisone Indomethacin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Fitzpatrick L R
Gastrointestinal Pharmacology Department, Rorer Central Research, Horsham, PA 19044.
Bostwick J S
Renzetti M
Pendleton R G
Decktor D L
References (29)
29 references, click to expand
  1. Metabolic fate of gossypol: the metabolism of 14C-gossypol in rats.
    Lipids. 1970 Nov;5(11):938-46 PMID: 5484207
  2. The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat.
    Br J Pharmacol. 1988 May;94(1):65-72 PMID: 2840994
  3. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.
    Gastroenterology. 1984 Dec;87(6):1344-50 PMID: 6092199
  4. A new approach to anti-inflammatory drugs.
    Biochem Pharmacol. 1979 Jun 15;28(12):1959-61 PMID: 110332
  5. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway.
    Biochem Pharmacol. 1986 Oct 15;35(20):3481-8 PMID: 3021173
  6. The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger.
    Agents Actions. 1987 Jun;21(1-2):191-4 PMID: 2888280
  7. Experimental production of diffuse colitis in rats.
    Digestion. 1978;17(2):135-50 PMID: 627326
  8. Time courses of the anti-anaphylactic and anti-inflammatory effects of dexamethasone in the rat and mouse.
    Br J Pharmacol. 1978 Apr;62(4):481-6 PMID: 656694
  9. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.
    Gastroenterology. 1989 Jan;96(1):29-36 PMID: 2535830
  10. Role of eicosanoids in human and experimental colitis.
    Dig Dis Sci. 1988 Mar;33(3 Suppl):58S-64S PMID: 2831015
  11. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
    Gut. 1987 Feb;28(2):190-5 PMID: 2881849
  12. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine.
    J Pharmacol Exp Ther. 1972 Jun;181(3):555-62 PMID: 4402374
  13. Actions of anticolitic drugs on a guinea-pig model of immune colitis.
    Agents Actions. 1982 Apr;12(1-2):239-42 PMID: 6123242
  14. Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine.
    Br J Pharmacol. 1978 Jan;62(1):61-6 PMID: 74266
  15. Inhibition of the A-23187-stimulated leukotriene and prostaglandin biosynthesis of rat basophil leukemia (RBL-1) cells by nonsteroidal anti-inflammatory drugs, antioxidants, and calcium channel blockers.
    Biochem Pharmacol. 1983 Oct 15;32(20):3023-6 PMID: 6315014
  16. Gossypol, a potent inhibitor of arachidonate 5- and 12-lipoxygenases.
    Biochim Biophys Acta. 1985 Mar 27;834(1):37-41 PMID: 3919771
  17. Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease.
    Gastroenterology. 1985 Jan;88(1 Pt 1):55-63 PMID: 3917261
  18. Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat.
    Br J Pharmacol. 1982 May;76(1):185-94 PMID: 6282373
  19. In vivo production of leukotriene B4 and leukotriene C4 in rabbit colitis. Relationship to inflammation.
    Gastroenterology. 1987 Jan;92(1):33-9 PMID: 3023167
  20. Inhibition of LTB4 binding to human neutrophils by nordihydroguaiaretic acid.
    Agents Actions. 1987 Aug;21(3-4):358-60 PMID: 2825484
  21. Leukotriene B4 and inflammatory disease.
    Agents Actions. 1988 Jun;24(1-2):114-9 PMID: 2841828
  22. Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.
    Gastroenterology. 1987 Jun;92(6):1998-2008 PMID: 2883067
  23. An experiment to determine the active therapeutic moiety of sulphasalazine.
    Lancet. 1977 Oct 29;2(8044):892-5 PMID: 72239
  24. Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury.
    Infect Immun. 1988 Aug;56(8):2101-8 PMID: 3397186
  25. The comparative prophylactic effects of sulphasalazine, prednisolone and azathioprine in experimental colonic ulceration.
    J Pharm Pharmacol. 1980 Dec;32(12):873-4 PMID: 6110761
  26. Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis.
    Gastroenterology. 1988 Apr;94(4):1006-13 PMID: 3345870
  27. Inflammation-induced intestinal hyperemia in the rat: role of neutrophils.
    Gastroenterology. 1988 Dec;95(6):1528-34 PMID: 2846403
  28. Hapten-induced model of chronic inflammation and ulceration in the rat colon.
    Gastroenterology. 1989 Mar;96(3):795-803 PMID: 2914642
  29. Experimental colitis studied by colonoscopy in the rat: effect of indomethacin.
    Gastrointest Endosc. 1983 May;29(2):77-82 PMID: 6574081
Article Info
Journal
Agents and actions
Abbr.
Agents Actions
ISSN
0065-4299
Published
1990-06-00
Pages
393-402
Language
English
Region
Switzerland
NLM ID
0213341
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]